title: Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery.
abstract: Nanoliposomes have an organized architecture that provides versatile functions. In this study, liposomes were used as an ocular carrier for nanogold capped with flucytosine antifungal drug. Gold nanoparticles were used as a contrasting agent that provides tracking of the drug to the posterior segment of the eye for treating fungal intraocular endophthalmitis. The nanoliposomes were prepared with varying molar ratios of lecithin, cholesterol, Span 60, a positive charge inducer (stearylamine), and a negative charge inducer (dicetyl phosphate). Formulation F6 (phosphatidylcholine, cholesterol, Span 60, and stearylamine at a molar ratio of 1:1:1:0.15) demonstrated the highest extent of drug released, which reached 7.043 mg/h. It had a zeta potential value of 42.5±2.12 mV and an average particle size approaching 135.1±12.0 nm. The ocular penetration of the selected nanoliposomes was evaluated in vivo using a computed tomography imaging technique. It was found that F6 had both the highest intraocular penetration depth (10.22±0.11 mm) as measured by the computed tomography and the highest antifungal efficacy when evaluated in vivo using 32 infected rabbits' eyes. The results showed a strong correlation between the average intraocular penetration of the nanoparticles capped with flucytosine and the percentage of the eyes healed. After 4 weeks, all the infected eyes (n=8) were significantly healed (P<0.01) when treated with liposomal formulation F6. Overall, the nanoliposomes encapsulating flucytosine have been proven efficient in treating the infected rabbits' eyes, which proves the efficiency of the nanoliposomes in delivering both the drug and the contrasting agent to the posterior segment of the eye.
authors.affiliation: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
authors.forename: Heba F
authors.initials: HF
authors.lastname: Salem
authors.affiliation: Department of Industrial Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
authors.forename: Sayed M
authors.initials: SM
authors.lastname: Ahmed
authors.affiliation: Department of Industrial Pharmacy, Faculty of Pharmacy, Deraya University, El-Minia, Egypt.
authors.forename: Mahmoud M
authors.initials: MM
authors.lastname: Omar
mesh_terms: D060433:Administration, Ophthalmic; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002626:Chemistry, Pharmaceutical / Q000379:methods; D016503:Drug Delivery Systems; D065546:Drug Liberation; D005079:Excipients / Q000737:chemistry; D005123:Eye / Q000378:metabolism / Q000382:microbiology; D015821:Eye Infections, Fungal / Q000188:drug therapy* / Q000382:microbiology; D005437:Flucytosine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006046:Gold / Q000737:chemistry; D008081:Liposomes; D053768:Metal Nanoparticles; D010316:Particle Size; D011817:Rabbits; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D005079:Excipients; D008081:Liposomes; D006046:Gold; D005437:Flucytosine
keywords: computed tomography imaging; fungal endophthalmitis; intraocular inflammation; nanoliposomes
references.citation: Anal Chem. 2011 Jun 1;83(11):4251-7
references.pmid: 21524056
references.citation: Int J Pharm. 2002 Sep 5;244(1-2):73-80
references.pmid: 12204566
references.citation: Ophthalmic Surg Lasers. 1996 Dec;27(12):1012-8
references.pmid: 8976520
references.citation: Int J Pharm Investig. 2014 Jul;4(3):112-8
references.pmid: 25126524
references.citation: AAPS PharmSciTech. 2010 Mar;11(1):241-6
references.pmid: 20151337
references.citation: Int J Pharm. 2006 Feb 3;308(1-2):140-8
references.pmid: 16356669
references.citation: J Pharm Sci. 1984 Nov;73(11):1559-63
references.pmid: 6520758
references.citation: J Ophthalmic Inflamm Infect. 2013 Sep 20;3(1):60
references.pmid: 24053550
references.citation: Invest Ophthalmol Vis Sci. 1982 Feb;22(2):220-7
references.pmid: 7056633
references.citation: Adv Drug Deliv Rev. 2008 Dec 14;60(15):1663-73
references.pmid: 18845195
references.citation: Drug Dev Ind Pharm. 2000 Mar;26(3):313-21
references.pmid: 10738648
references.citation: J Microencapsul. 1999 May-Jun;16(3):357-67
references.pmid: 10340220
references.citation: Br J Ophthalmol. 1987 May;71(5):331-43
references.pmid: 3580349
references.citation: Int J Pharm. 2003 Jun 4;258(1-2):141-51
references.pmid: 12753761
references.citation: J Nanobiotechnology. 2012 May 06;10:19
references.pmid: 22559747
references.citation: Retina. 1988;8(3):210-5
references.pmid: 3266021
references.citation: Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1102-8
references.pmid: 10988137
references.citation: Pharm Dev Technol. 2000;5(4):521-32
references.pmid: 11109251
references.citation: J Pharm Sci. 1998 Dec;87(12):1479-88
references.pmid: 10189253
references.citation: J Pharm Sci. 2010 Oct;99(10):4317-25
references.pmid: 20310026
references.citation: J Microencapsul. 1998 Jul-Aug;15(4):473-83
references.pmid: 9651869
references.citation: Am J Ophthalmol. 1973 Oct;76(4):584-8
references.pmid: 4582798
references.citation: Int J Pharm. 1999 Aug 5;185(1):23-35
references.pmid: 10425362
references.citation: Clin Microbiol Rev. 2000 Oct;13(4):662-85
references.pmid: 11023963
references.citation: PLoS One. 2013;8(2):e58208
references.pmid: 23469154
references.citation: Arch Ophthalmol. 1980 Jul;98(7):1216-20
references.pmid: 6967308
references.citation: Surv Ophthalmol. 1985 Mar-Apr;29(5):335-48
references.pmid: 3992472
references.citation: J Control Release. 2006 Sep 12;114(3):343-7
references.pmid: 16876898
references.citation: Nanotechnology. 2009 Dec 16;20(50):505101
references.pmid: 19923650
references.citation: J Ocul Pharmacol Ther. 2012 Oct;28(5):484-96
references.pmid: 22694593
references.citation: Antimicrob Agents Chemother. 1979 Nov;16(5):529-32
references.pmid: 525993
references.citation: Rev Latinoam Microbiol. 2006 Jul-Dec;48(3-4):238-46
references.pmid: 18293657
references.citation: J Drug Target. 1998;6(4):309-13
references.pmid: 9894698
references.citation: Int J Nanomedicine. 2014 Apr 29;9:2005-17
references.pmid: 24851047
references.citation: Br Med J. 1964 Jul 18;2(5402):178-9
references.pmid: 14150899
references.citation: AAPS PharmSciTech. 2007 Jan 05;8(1):1
references.pmid: 17408209
references.citation: Clin Exp Ophthalmol. 2015 May-Jun;43(4):358-66
references.pmid: 24533647
references.citation: Am J Ophthalmol. 2005 Jan;139(1):135-40
references.pmid: 15652837
references.citation: Doc Ophthalmol. 1997;93(1-2):149-57
references.pmid: 9476613
references.citation: Micron. 2007;38(8):841-7
references.pmid: 17689087
references.citation: Acta Ophthalmol. 2008 Aug;86(5):525-32
references.pmid: 18752527
references.citation: J Antimicrob Chemother. 2000 Aug;46(2):171-9
references.pmid: 10933638
references.citation: Colloids Surf B Biointerfaces. 2006 Mar 15;48(2):112-8
references.pmid: 16520025
references.citation: Anal Chem. 2000 Nov 15;72(22):5535-41
references.pmid: 11101228
references.citation: Invest Ophthalmol Vis Sci. 2003 Jan;44(1):210-6
references.pmid: 12506077
references.citation: J Mater Sci Mater Med. 2008 Dec;19(12):3603-9
references.pmid: 18642059
references.citation: Int J Nanomedicine. 2006;1(1):51-7
references.pmid: 16467923
references.citation: Small. 2008 Jan;4(1):153-9
references.pmid: 18081130
references.citation: Small. 2005 Mar;1(3):325-7
references.pmid: 17193451
references.citation: Cornea. 2005 May;24(4):449-52
references.pmid: 15829804
references.citation: J Pharm Pharmacol. 1990 Jun;42(6):397-400
references.pmid: 1979618
references.citation: Antimicrob Agents Chemother. 2003 May;47(5):1647-51
references.pmid: 12709335
references.citation: Micron. 2011 Apr;42(3):207-27
references.pmid: 20952201
references.citation: J Pharm Sci. 1963 Dec;52:1145-9
references.pmid: 14088963
references.citation: Int J Pharm. 2005 Dec 8;306(1-2):71-82
references.pmid: 16263229
references.citation: Acta Ophthalmol (Copenh). 1991 Dec;69(6):744-9
references.pmid: 1789089
references.citation: J Pharm Pharmacol. 1996 Nov;48(11):1147-52
references.pmid: 8961163
references.citation: Int J Pharm. 1999 Nov 10;190(1):63-71
references.pmid: 10528098